These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV]. Wang G, Dong XY, Tian WH, Yu CJ, Zheng G, Gao J, Wang GJ, Wei GC, Zhou YS, Wu XB. Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931 [Abstract] [Full Text] [Related]
4. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection. Suga M, Arima K, Yachi A. Digestion; 1991 Sep; 50(3-4):153-61. PubMed ID: 1812042 [Abstract] [Full Text] [Related]
6. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis. Zhang Q, Li ZQ, Liu H, Yang JH. World J Gastroenterol; 2012 Jan 28; 18(4):349-55. PubMed ID: 22294841 [Abstract] [Full Text] [Related]
7. In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans. Cupps TR, Hoofnagle JH, Ellis RW, Miller WJ, Gerin JL, Volkman DJ, Haas-Smith SA. J Infect Dis; 1990 Mar 28; 161(3):412-9. PubMed ID: 2313122 [Abstract] [Full Text] [Related]
8. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance. Theilmann L, Goeser T. Hepatogastroenterology; 1991 Feb 28; 38(1):10-3. PubMed ID: 1709133 [Abstract] [Full Text] [Related]
9. [Antibody responses in human being to pre-S2 and related hepatitis B virus-envelope antigens in vivo and in vitro]. Ogata M, Ishikawa H, Kato Y, Honta S, Yoshida H, Yasuda H, Ohto H, Watanabe N. Rinsho Byori; 1991 Jan 28; 39(1):3-13. PubMed ID: 1826138 [Abstract] [Full Text] [Related]
12. Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccine. Hurni WM, Roehm RR, Miller WJ. J Med Virol; 1990 Feb 28; 30(2):146-50. PubMed ID: 2313274 [Abstract] [Full Text] [Related]
14. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen. Ryu CJ, Gripon P, Park HR, Park SS, Kim YK, Guguen-Guillouzo C, Yoo OJ, Hong HJ. J Med Virol; 1997 Jun 28; 52(2):226-33. PubMed ID: 9179773 [Abstract] [Full Text] [Related]
15. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees. Hong HJ, Ryu CJ, Hur H, Kim S, Oh HK, Oh MS, Park SY. Virology; 2004 Jan 05; 318(1):134-41. PubMed ID: 14972542 [Abstract] [Full Text] [Related]
16. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. J Immunol; 1989 Oct 15; 143(8):2650-5. PubMed ID: 2477450 [Abstract] [Full Text] [Related]
17. Antigenic mapping of the surface proteins of infectious hepatitis B virus particles. Petit MA, Capel F, Riottot MM, Dauguet C, Pillot J. J Gen Virol; 1987 Nov 15; 68 ( Pt 11)():2759-67. PubMed ID: 2445903 [Abstract] [Full Text] [Related]
18. [C3d enhances the immune response against HBV-preS2/S following gene immunization in mice]. Guan QD, Wang LX, Guo Q, Zhang JP, Xu W, Wang Y, Xiong SD. Zhonghua Yi Xue Za Zhi; 2005 Jan 12; 85(2):101-5. PubMed ID: 15774215 [Abstract] [Full Text] [Related]
19. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein. Emini EA, Larson V, Eichberg J, Conard P, Garsky VM, Lee DR, Ellis RW, Miller WJ, Anderson CA, Gerety RJ. J Med Virol; 1989 May 12; 28(1):7-12. PubMed ID: 2723618 [Abstract] [Full Text] [Related]
20. Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw. Neurath AR, Kent SB, Adamowicz P, Riottot MM, Price P, Strick N, Parker K, Petit MA, Budkowska A, Girard M. Mol Immunol; 1987 Jun 12; 24(6):561-8. PubMed ID: 3657796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]